| Year |
Citation |
Score |
| 2024 |
Yaghi S, Shu L, Mandel DM, Leon Guerrero CR, Henninger N, Muppa J, Affan M, Ul Haq Lodhi O, Heldner MR, Antonenko K, Seiffge DJ, Arnold M, Salehi Omran S, Crandall RC, Lester E, ... ... Simpkins AN, et al. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. PMID 38335240 DOI: 10.1161/STROKEAHA.123.045731 |
0.317 |
|
| 2022 |
Shu L, Bakradze E, Omran SS, Giles J, Amar J, Henninger N, Elnazeir M, Liberman A, Moncrieffe K, Rotblat J, Sharma R, Cheng Y, Zubair AS, Simpkins A, Li G, et al. Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. Neurology. PMID 36123126 DOI: 10.1212/WNL.0000000000201122 |
0.337 |
|
| 2021 |
Farooqui AB, Humbert ML, Montague MS, Doré S, Simpkins AN. Cerebral Venous Thrombosis and Hypercoagulability Associated With In Vitro Fertilization. Stroke. STROKEAHA121035962. PMID 34348473 DOI: 10.1161/STROKEAHA.121.035962 |
0.354 |
|
| 2019 |
Nadareishvili Z, Kelley D, Luby M, Simpkins AN, Leigh R, Lynch JK, Hsia AW, Benson RT, Johnson KR, Hallenbeck JM, Latour LL. Molecular signature of penumbra in acute ischemic stroke: a pilot transcriptomics study. Annals of Clinical and Translational Neurology. 6: 817-820. PMID 31020007 DOI: 10.1002/acn3.757 |
0.372 |
|
| 2019 |
Nadareishvili Z, Simpkins AN, Hitomi E, Reyes D, Leigh R. Post-Stroke Blood-Brain Barrier Disruption and Poor Functional Outcome in Patients Receiving Thrombolytic Therapy. Cerebrovascular Diseases (Basel, Switzerland). 1-8. PMID 30970357 DOI: 10.1159/000499666 |
0.35 |
|
| 2018 |
Majidi S, Simpkins AN, Leigh R. The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30508260 DOI: 10.1111/jon.12587 |
0.411 |
|
| 2017 |
Gupta N, Simpkins AN, Hitomi E, Dias C, Leigh R. White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 29100854 DOI: 10.1016/j.jstrokecerebrovasdis.2017.09.026 |
0.335 |
|
| 2016 |
Simpkins AN, Dias C, Leigh R. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia. Stroke; a Journal of Cerebral Circulation. PMID 27462115 DOI: 10.1161/STROKEAHA.116.013805 |
0.338 |
|
| 2011 |
Imig JD, Simpkins AN, Renic M, Harder DR. Cytochrome P450 eicosanoids and cerebral vascular function. Expert Reviews in Molecular Medicine. 13: e7. PMID 21356152 DOI: 10.1017/S1462399411001773 |
0.63 |
|
| 2010 |
Simpkins AN, Rudic RD, Roy S, Tsai HJ, Hammock BD, Imig JD. Soluble epoxide hydrolase inhibition modulates vascular remodeling. American Journal of Physiology. Heart and Circulatory Physiology. 298: H795-806. PMID 20035028 DOI: 10.1152/Ajpheart.00543.2009 |
0.62 |
|
| 2009 |
Simpkins AN, Rudic RD, Schreihofer DA, Roy S, Manhiani M, Tsai HJ, Hammock BD, Imig JD. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection. The American Journal of Pathology. 174: 2086-95. PMID 19435785 DOI: 10.2353/Ajpath.2009.080544 |
0.315 |
|
| 2004 |
Hilali HM, Simpkins AN, Hill WD, Waller JL, Knight RA, Fagan SC. Single slice method for quantification of hemorrhagic transformation using direct ELISA. Neurological Research. 26: 93-8. PMID 14977065 DOI: 10.1179/016164104773026606 |
0.357 |
|
| Show low-probability matches. |